For NextCure, a fast-growing, publicly-traded (Nasdaq: NXTC) clinical-stage biotech located in Beltsville, Maryland, choosing to invest in and build capabilities in-house aligned with its mission to serve patients that do not respond to existing therapies.
NextCure Launches New GLP Lab, Expands In-House Capabilities
